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exons to ensure that the PCR product represents the specific messenger RNA species and
not genomic DNA. PCR was performed using Taq DNA polymerase (Eppendorf). The
DNA sequence of the primers is summarized in Supplementary Information.
DNA ploidy and polymorphism
DNA contents per cell were determined by staining cells with propidium iodide and
subsequent FACS analysis.
Genomic DNA were extracted from embryonic stem cells, bone marrow cells, and
BMESL cells. DNA was amplified using microsatellite primers (D9MIT48, Research
Genetics) detecting polymorphisms between the bone marrow genome (mostly C57BL/6)
and the embryonic stem cell genome (129/Sv), separated on 5% agarose gel and visualized
by ethidium bromide staining.
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Recent reports have suggested that mammalian stem cells resid-
ing in one tissue may have the capacity to produce differentiated
cell types for other tissues and organs1 – 9. Here we define a
mechanism by which progenitor cells of the central nervous
system can give rise to non-neural derivatives. Cells taken from
mouse brain were co-cultured with pluripotent embryonic stem
cells. Following selection for a transgenic marker carried only by
the brain cells, undifferentiated stem cells are recovered in which
the brain cell genome has undergone epigenetic reprogramming.
However, these cells also carry a transgenic marker and chromo-
somes derived from the embryonic stem cells. Therefore the
altered phenotype does not arise by direct conversion of brain to
embryonic stem cell but rather through spontaneous generation
of hybrid cells. The tetraploid hybrids exhibit full pluripotent
character, including multilineage contribution to chimaeras. We
propose that transdetermination consequent to cell fusion10
could underlie many observations otherwise attributed to an
intrinsic plasticity of tissue stem cells9.
The capacity to generate differentiated cell types representing all
three definitive germ layers has traditionally been considered a
property reserved to cells of the inner cell mass and epiblast in the
early embryo and derivative embryonal carcinoma and embryonic
stem (ES) cells in vitro11,12. Recently, however, remarkable potencies
have been ascribed to stem cells isolated from various fetal and adult
tissues including the central nervous system (CNS). CNS stem cells
have been reported to contribute to haematopoietic lineages when
injected into irradiated mice6, to produce muscle when co-cultured
with skeletal myoblasts13, and to colonize multiple fetal lineages
when introduced into pre-implantation embryos5. A further cir-
cumstance in which nervous system stem cells seem to change
determination is during co-culture with differentiating ES cells,
when they form multinucleated myotubes5. We investigated the
basis of these phenomena and in particular whether during co-
culture CNS cells may first convert to pluripotent ES cells as a route
to generating other cell types.
We used distinct transgenic markers to isolate and identify
descendants of both the ES cells and the CNS cells (Fig. 1). ZIN40
mice constitutively co-express resistance to the selection agent G418
and nuclear b-galactosidase activity14. Oct4-GiP mice express
puromycin resistance and green fluorescent protein (GFP) exclu-
sively in pluripotent and germline cells under direction of regulat-
ory sequences of the mouse Oct4 gene15. Neurosphere cultures5
were initiated from dissociated forebrains of transgenic fetuses at
embryonic day 14.5 carrying either of these markers. Neurospheres
were expanded for 3 days and then combined with HT2 ES cells.
HT2 cells carry the hygromycin phosphotransferase–herpes sim-
plex virus (HSV) thymidine kinase fusion gene (Hytk)16 inserted
into the Oct4 locus by homologous recombination17,18. Selection
was subsequently applied with G418 or puromycin as appropriate to
eliminate the HT2 cells. After 2–4 weeks, proliferating cells with
undifferentiated ES cell morphology re-emerged (Fig. 2b). Colonies
were recovered from each of 23 independent co-cultures. These
included one experiment in which fetal telencephalic cells were
combined directly with ES cells without prior preparation of
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neurospheres. Cells surviving selection expressed nuclear b-galacto-
sidase (ZIN40 cells) or cytoplasmic GFP (Oct4-GiP cells) as appro-
priate. Expression of the Oct4-GiP transgene (Fig. 1b) is striking
because, like Oct4 itself, this transgene is expressed only in germline
and pluripotent cells and is not active in CNS cells in vivo or in
primary culture (ref. 15 and our unpublished observations). GFP
activity is therefore indicative of at least partial epigenetic reprogram-
ming of the somatic cell genome to a state of pluripotency. Thus it
appeared that ES cells could be generated from fetal brain cells.
We then tested these cells for expression of the hygromycin
resistance marker carried only by HT2 ES cells (Fig. 1a). The
cultures were completely resistant to hygromycin. Furthermore,
they were sensitive to gancyclovir, which kills only cells harbouring
the HSV Tk transgene. To exclude the possibility that inefficient
selection could have given rise to mixed cultures, we generated
several clonal derivatives by limiting dilution. The clonal isolates all
exhibited fetal and ES cell resistance/sensitivity phenotypes. There-
fore transgenic selection markers of different origin are co-
expressed in individual cells.
We inferred that the selected cells were likely to be hybrids.
Consistent with this, they had enlarged nuclei with multiple
nucleoli (Fig. 2a, b). To test this interpretation directly, we prepared
metaphase chromosome spreads (Fig. 2c). Analysis of 18 indepen-
dent isolates revealed a tetraploid or near-tetraploid complement in
all cases. The ES cells are male, and where a female fetus had been
used as the source of brain cells, the sex chromosome complement
was XXXY. The strain origin of chromosomes 8 and 14 can readily
be discriminated owing to polymorphisms in centromeric hetero-
chromatin19. Both strain 129 chromosomes of ES cell origin and
non-strain 129 chromosomes of transgenic mouse origin were
present in three separate isolates examined in this way (Fig. 2d).
These observations can be explained only by the formation of cell
hybrids between CNS and ES cells.
The hybrid cells expressed the ES cell markers12 alkaline phos-
phatase and stage-specific embryonic antigen (SSEA)-1 (data not
shown). They expressed the essential pluripotent cell transcription
factor Oct-418,20 as well as the Oct4-GiP transgene. Like normal ES
cells, they were dependent on the self-renewal factor leukaemia
inhibitory factor (LIF) to suppress differentiation12. On aggregation
they formed embryoid bodies21 containing both extra-embryonic
endoderm and spontaneously contracting cardiomyocytes (Fig. 3).
Embryoid bodies treated with retinoic acid22 gave rise to neurons.
Thus the hybrids have in vitro self-renewal and differentiation
properties similar to those of regular ES cells12. Hybrids produced
by electrofusion of ES cells with thymocytes have similarly been
found to exhibit ES cell characteristics23.
We examined the capacity for incorporation into embryonic
development by blastocyst injection. Contributions to fetal tissues
were detected in 8 of 23 transferred embryos by b-galactosidase
staining for the ZIN40 marker (Fig. 4a). The contributions were
modest by comparison with standard ES cells and uneven between
tissues, but this is expected owing to competitive overgrowth of
tetraploid hybrid cells by diploid host cells24. Interestingly, 1 of 14
live-born mice showed overt coat-colour chimaerism (Fig. 4b). This
animal was euthanized and we analysed the internal organs for
expression of nuclear b-galactosidase. Staining was detected in
intestine, kidney, heart and most prominently in liver (Fig. 4c). A
proportion of tetraploid hepatocytes is normally present in the liver,
which may account for the persistent contribution of hybrid cells in
this organ. These observations establish that the presence of a
genome derived from a brain cell is not prohibitive for multilineage
contribution of ES cell hybrids.
Finally we investigated whether similar fusion events could occur
with cells isolated from adult brain. A modified schedule for co-
culture and selection was adopted to allow for the comparatively
slower proliferation rate of adult-derived neurospheres. Neuro-















Figure 1 Isolation and identification of descendants of ES and CNS cells. a, Diagram of
experimental strategy. b, Expression of GFP in undifferentiated cells isolated after co-






Figure 2 Morphology and chromosomal constitution. a, b. Photomicrographs of parental
ES cells (a) and cells isolated after co-culture (b) showing enlarged nuclei with multiple
nucleoli in cells with otherwise typical ES cell morphology. Scale bar, 25 mm. c,
Metaphase spread showing tetraploid chromosome complement after co-culture of adult
brain neurospheres and ES cells. d, Strain 129 and non-strain 129 chromosomes in cells
derived from co-culture. Arrowheads indicate the polymorphic centromeric C bands that
are diagnostically reduced in strain 129 chromosomes and large in MF1 or C57BL/6
chromosomes of the transgenic mice.
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tously the tauGFP fusion protein linked with puromycin resist-
ance25. The lateral ventricles of an 8-week-old female mouse were
dissociated and neurospheres were propagated for 2 weeks as
described5. These neurosphere cells were combined in a 10:1 ratio
with ES cells in adherent culture. The co-culture was maintained in
neural stem cell medium supplemented with LIF for 1 week. The
culture was then transferred to ES cell medium and expanded for a
further week before applying puromycin selection. After 2 weeks of
selection, proliferating colonies of tauGFP-expressing ES cells
appeared. These cells had large nuclei and multiple nucleoli as
above. Chromosome preparations confirmed that they were tetra-
ploid with an XXXY complement (Fig. 2c) and contained both
strain 129 and non-strain 129 chromosomes 8 and 14.
The frequency of hybrid isolation in these experiments is between
1024 and 1025 per brain cell plated, although note that we have
made no efforts at optimization. There is no fusogen present under
our culture conditions, implying that the hybrids are generated by
spontaneous fusion between ES cells and CNS cells. The phenom-
enon is not dependent on the use of HT2 cells because an
independently derived ES cell line, 46C, was used in the fusion
with adult neurosphere cells. We have also obtained hybrids from
co-cultures between ES cells. Spontaneous fusion between mam-
malian cells was originally documented in 196126,27. This provided
the foundation for development of somatic cell genetics and the
appreciation that cell specification can be reprogrammed in
hybrids10. This work has been overlooked in recent reports of
transdetermination and transdifferentiation1 – 8,13, resulting in a
major challenge to the concept of progressive lineage restriction
during development9. However, as we have shown here, the fact that
mammalian cells can spontaneously form hybrids presents an
alternative explanation for the apparent ability of cells from one
tissue to generate progeny of another type. Future claims of cell
plasticity should therefore examine the presence not just of donor
cell markers but also of host cell markers in any putative trans-
determination product. A
Methods
Embryonic stem cells and hybrid cells were maintained in LIF-supplemented medium
without feeders28. HT2 and 46C ES cells are of pure inbred 1290la origin. Transgenic mice
are on mixed 129 £ MF1 (ZIN40 and Oct4-GiP) and 129 £ C57BL/6 (tauGFP)
backgrounds. Neurosphere cultures were initiated and expanded in DMEM/F12 medium
with N2 and B27 supplements plus fibroblast growth factor-2 (10 ng ml21)5. Dissociated
fetal neurosphere cells and ES cells were mixed in a 2:1 ratio and plated on dishes coated with
poly-D-lysine and laminin at 1–1.5 £ 104 cells cm22. Cultures were maintained in neural
stem cell medium for 48 h, then changed to ES cell medium containing fetal calf serum and
LIF. G418 (200–400 mg ml21) was added after a further 2 days of co-culture, but puromycin
(1 mg ml21) only after 6 days because the Oct4-GiP transgene is not expressed in brain cells.
In the case of adult neurosphere cells, the co-culture was initiated at a 10:1 ratio of brain cells
to ES cells and maintained for 2 weeks before application of puromycin selection. ES cell
differentiation and chimaera production followed standard protocols29.
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Figure 4 Contribution of ZIN40/HT2 hybrid cells to chimaeras. a, b-galactosidase
staining of fetal chimaera at embryonic day 11.5, slightly retarded. b, Adult mouse
chimaera. c, b-galactosidase staining of liver from an adult mouse chimaera.
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The Drosophila protein Shaggy (Sgg, also known as Zeste-white3,
Zw3) and its vertebrate orthologue glycogen synthase kinase 3
(GSK3) are inhibitory components of the Wingless (Wg) and
Wnt pathways1. Here we show that Sgg is also a negative regulator
in the Hedgehog (Hh) pathway. In Drosophila, Hh acts both by
blocking the proteolytic processing of full-length Cubitus inter-
ruptus, Ci (Ci155), to generate a truncated repressor form (Ci75),
and by stimulating the activity of accumulated Ci155 (refs 2 – 6).
Loss of sgg gene function results in a cell-autonomous accumu-
lation of high levels of Ci155 and the ectopic expression of Hh-
responsive genes including decapentaplegic (dpp) and wg. Sim-
ultaneous removal of sgg and Suppressor of fused, Su(fu)7, results
in wing duplications similar to those caused by ectopic Hh
signalling. Ci is phosphorylated by GSK3 after a primed phos-
phorylation by protein kinase A (PKA), and mutating GSK3-
phosphorylation sites in Ci blocks its processing and prevents the
production of the repressor form. We propose that Sgg/GSK3 acts
in conjunction with PKA to cause hyperphosphorylation of Ci,
which targets it for proteolytic processing, and that Hh opposes
Ci proteolysis by promoting its dephosphorylation.
The Hh family of secreted proteins controls cell growth and
patterning in many principal developmental processes in both
vertebrates and invertebrates8. Moreover, mutations in components
of the Hh signalling pathway have been implicated in many human
disorders, including cancer9. During Drosophila limb development,
posterior (P)-compartment cells express and secrete Hh that
induces adjacent anterior (A)-compartment cells to express target
genes including dpp, wg (leg only) and patched (ptc) by regulating
the transcription factor Ci4,10,11. In A-compartment cells distant
from the AP compartment boundary, Ci is processed to generate a
truncated repressor form (Ci75) that represses a subset of Hh-
responsive genes including dpp2,4. In A-compartment cells adjacent
to the AP compartment border, Hh signalling blocks Ci processing
to generate Ci75, and causes the accumulation of full-length Ci
(Ci155)2. In addition, high levels of Hh stimulate a distinct
transcriptional activation activity of Ci155, which is required for
the expression of Hh-responsive genes such as ptc3,4,12.
In both wing and leg discs, loss of sgg function in the A
compartment either by using sgg mutations or by overexpressing
a dominant negative form of GSK3 (DN-GSK3)13 causes the
accumulation of high levels of Ci155 in a cell-autonomous fashion
without affecting ci-lacZ expression (Fig. 1a, b, e, h, j– l, and see
Supplementary Information). In wing discs, anterior sgg2 cells or
DN-GSK3-expressing cells located outside the wing pouch region
ectopically express dpp, which is repressed by Ci75 (Fig. 1c, d).
However, anterior sgg2 cells do not ectopically activate ptc, which is
activated by Ci155 (Fig. 1f). In leg discs, anterodorsal sgg2 cells
distant from the AP boundary ectopically express wg and low levels
of dpp (Fig. 1g–i), a phenotype similar to that associated with sgg
PKA double-mutant cells in which both Wg and Hh signalling
pathways are ectopically activated14. As in the case of wing discs,
Figure 1 Ectopic Hh signalling activity in sgg2 cells. a–c, A wing disc carrying sgg2
clones and showing the expression of a marker gene (a), Ci155 (b) and dpp-lacZ (c).
sgg2 cells are recognized by strong Myc staining. Anterior sgg2 cells accumulate high
levels of Ci155 and ectopically express dpp-lacZ. The inset in b shows an enlarged view of
the anterior sgg2 clone (arrow in a). d, e, A wing disc containing clones of cells that
express UAS-DN-GSK3 using actin5c . CD2 . Gal4. Anterior DN-GSK3-expressing
cells accumulate high levels of Ci155 (arrows in e) and ectopically express dpp-lacZ
(arrows in d). f, A wing disc carrying sgg2 mutant clones and exhibiting the expression of
Ci155 and ptc-lacZ. Anterior sgg2 mutant clones do not ectopically activate ptc-lacZ
(arrows). g– i, Leg discs carrying sgg2 clones and showing the expression of wg-lacZ (g),
Ci155 (h) and dpp-lacZ (i). Anterodorsal sgg2 cells accumulate high levels of Ci155 (h)
and ectopically express low levels of wg-lacZ (g) and dpp-lacZ (i). j– l, A wing disc
carrying sgg2 clones and showing the expression of ci-lacZ and Ci155. sgg2 cells (arrow)
do not express ci-lacZ at higher levels.
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